Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001239616 | SCV001412500 | uncertain significance | Granulomatous disease, chronic, X-linked | 2021-09-01 | criteria provided, single submitter | clinical testing | This sequence change replaces alanine with threonine at codon 431 of the CYBB protein (p.Ala431Thr). The alanine residue is highly conserved and there is a small physicochemical difference between alanine and threonine. This variant is not present in population databases (ExAC no frequency). This missense change has been observed in individual(s) with chronic granulomatous disease (PMID: 24276928). Algorithms developed to predict the effect of missense changes on protein structure and function (SIFT, PolyPhen-2, Align-GVGD) all suggest that this variant is likely to be tolerated. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |
Fulgent Genetics, |
RCV002484309 | SCV002782022 | uncertain significance | X-linked Mendelian susceptibility to mycobacterial diseases due to CYBB deficiency; Granulomatous disease, chronic, X-linked | 2021-08-04 | criteria provided, single submitter | clinical testing | |
Natera, |
RCV001828926 | SCV002087146 | uncertain significance | Chronic granulomatous disease | 2020-07-14 | no assertion criteria provided | clinical testing |